📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1. (2018)

First Author: Barini E

Attributed to: Accelerating translational research through Cardiff University’s Clinical Innovation pipeline funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cbic.201700500

PubMed Identifier: 29226533

Publication URI: http://europepmc.org/abstract/MED/29226533

Type: Journal Article/Review

Volume: 19

Parent Publication: Chembiochem : a European journal of chemical biology

Issue: 5

ISSN: 1439-4227